FDC
FDC Share Price Chart
FDC last traded at ₹342.15 (2026-10-13). Over the past month the stock moved -1.3%, three months the stock moved -15.2%, year the stock moved -29.6%. Its closing range over 52 weeks is ₹321.75 – ₹460.70, with the latest close 25.7% below the high.
Closing prices up to 2026-10-13.
About FDC
FDC (Fairdeal Corporation) Ltd Limited (found in 1936) is among India’s leading fully integrated pharmaceutical companies. The Company is a pioneer in the manufacture of specialized formulations, and among the world’s foremost manufacturers and marketers of Oral Rehydration Salts (ORS). Some of FDC’s leading brands in India include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zathrin, Zipod, Cotaryl and Mycoderm in the domestic and international markets.[1]
Revenue Breakup FY25[1] Formulations: 92%, Bulk Drugs : 6%, Profit share - Formulation: 2%
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), FDC reported sales of ₹668.00 crore (+3.1%) and net profit of ₹132.00 crore (+9.1%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 668.00 | 143.00 | 21.00 | 132.00 | 8.14 |
| Mar 2026 | 585.00 | 106.00 | 18.00 | 103.00 | 6.35 |
| Dec 2025 | 465.00 | 52.00 | 11.00 | 28.00 | 1.74 |
| Sep 2025 | 473.00 | 34.00 | 7.00 | 28.00 | 1.74 |
| Jun 2025 | 648.00 | 140.00 | 22.00 | 121.00 | 7.45 |
| Mar 2025 | 492.00 | 54.00 | 11.00 | 39.00 | 2.38 |
| Dec 2024 | 464.00 | 47.00 | 10.00 | 37.00 | 2.28 |
| Sep 2024 | 514.00 | 70.00 | 14.00 | 72.00 | 4.42 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +5.8% | +1.3% | +6.5% | +1.6% | -8.0% | +0.2% | +18.9% | +3.1% |
| Operating profit growth | -7.9% | -44.0% | -3.6% | -4.8% | -51.4% | +10.6% | +96.3% | +2.1% |
| Net profit growth | +2.9% | -53.2% | -15.2% | +1.7% | -61.1% | -24.3% | +164.1% | +9.1% |
| EPS growth | +3.0% | -53.2% | -16.2% | +1.9% | -60.6% | -23.7% | +166.8% | +9.3% |
| OPM % | 14.0% | 10.0% | 11.0% | 22.0% | 7.0% | 11.0% | 18.0% | 21.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), FDC reported sales of ₹2,171.00 crore (+3.0%) and net profit of ₹281.00 crore (+5.2%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 2,171 | 346.00 | 16.00 | 281.00 | 17.29 |
| Mar 2025 | 2,108 | 325.00 | 15.00 | 267.00 | 16.39 |
| Mar 2024 | 1,943 | 339.00 | 17.00 | 305.00 | 18.75 |
| Mar 2023 | 1,784 | 251.00 | 14.00 | 194.00 | 11.70 |
| Mar 2022 | 1,525 | 254.00 | 17.00 | 216.00 | 12.82 |
| Mar 2021 | 1,331 | 334.00 | 25.00 | 301.00 | 17.85 |
| Mar 2020 | 1,341 | 304.00 | 23.00 | 240.00 | 14.03 |
| Mar 2019 | 1,089 | 229.00 | 21.00 | 170.00 | 9.74 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +1.4% | +23.1% | -0.7% | +14.6% | +17.0% | +8.9% | +8.5% | +3.0% |
| Operating profit growth | -1.7% | +32.8% | +9.9% | -24.0% | -1.2% | +35.1% | -4.1% | +6.5% |
| Net profit growth | -2.3% | +41.2% | +25.4% | -28.2% | -10.2% | +57.2% | -12.5% | +5.2% |
| EPS growth | -2.1% | +44.0% | +27.2% | -28.2% | -8.7% | +60.3% | -12.6% | +5.5% |
| OPM % | 21.0% | 23.0% | 25.0% | 17.0% | 14.0% | 17.0% | 15.0% | 16.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for FDC.
Get Free AI Stock Analysis FREE →Latest News
-
Stocks to Watch Today, August 28, 2026: THOMAS COOK (INDIA) LTD, Dr. Agrawals Eye Hospital, Star Cement, FDC and Great Eastern Shipping Company - scanx.trade
-
Maharashtra FDA Seizes FDC Enerzal Stock Over Misbranding Allegations - scanx.trade
-
FDC Limited Schedules Board Meeting on May 27, 2026 to Approve FY26 Audited Financial Results - scanx.trade
-
FDC Limited Issues Corrigendum to Postal Ballot Notice, Corrects Resolution Type for Independent Director Appointment - scanx.trade
-
FDC Limited Promoters Declare 69.66% Shareholding With Zero Encumbrance for FY26 - scanx.trade
-
Drugmaker FDC goes to court on similar-sounding electrolyte drink eRZL from J&J/Kenvue
-
LTIMindtree partners with IFFI, NFDC to launch AI Film Festival and Hackathon
Frequently Asked Questions
What is FDC's current stock price?
FDC shares were last quoted at ₹342.15 (+3.6% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of FDC?
FDC has a price-to-earnings (P/E) ratio of 18.98 and a price-to-book (P/B) ratio of 2.12. The industry P/E is 53.33.
What is the 52-week high and low of FDC?
The 52-week high of FDC is ₹473.30 and the 52-week low is ₹314.75.
What is the market cap of FDC?
The market capitalisation of FDC is about ₹5,552.64 crore.
How did FDC perform in its latest quarterly results?
In the latest quarter (Jun 2026), FDC reported sales of ₹668.00 crore (+3.1%) and net profit of ₹132.00 crore (+9.1%), compared with the same quarter last year.
Is FDC a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, FDC has a 3-year ROE of 13.00%, 3-year profit growth of 16.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in FDC?
Promoters hold about 69.66% of FDC.
Which sector does FDC belong to?
FDC belongs to the Pharmaceuticals & Drugs sector.